country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-139181

Copy Link Print Information

NR160

Name: NR160
Brand: MedChemExpress
SKU: HY-139181
Price: 190.00 USD
Availability: InStock
Rating: 5 (1 reviews)

Kundenbewertung

Based on 1 Customer Validation

NR160 is a selective HDAC6 inhibitor with an IC₅₀ value of 30 nM. NR160 shows low cytotoxicity against leukemia cell line. NR160 augments the apoptosis induction of Bortezomib (HY-10227) (proteasome inhibitor), Epirubicin (HY-13624) and Daunorubicin (HY-13062A) significantly.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 98.9%
CAS. Nr.: 2484895-50-1
Formel: C₂₅H₂₁F₃N₆O₃
Molecular Weight:510.47

Speicherung:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

NR160 Chemical Structure

CAS. Nr.: 2484895-50-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

^[1]

HDAC6

30 nM (IC₅₀)

Alle HDAC Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
CCRF-HSB-2	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human CCRF-HSB-2 cells Antiproliferative activity against human CCRF-HSB-2 cells	[PMID: 37875056]
CCRF-HSB-2	IC₅₀	51.8 μM Compound: 6l, NR-160	Cytotoxicity in human CCRF-HSB-2 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human CCRF-HSB-2 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]
HL-60	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human HL-60 cells Antiproliferative activity against human HL-60 cells	[PMID: 37875056]
HL-60	IC₅₀	42.9 μM Compound: 6l, NR-160	Cytotoxicity in human HL-60 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human HL-60 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]
Jurkat	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human Jurkat cells Antiproliferative activity against human Jurkat cells	[PMID: 37875056]
Jurkat	IC₅₀	32.1 μM Compound: 6l, NR-160	Cytotoxicity in human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]
K562	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human K562 cells Antiproliferative activity against human K562 cells	[PMID: 37875056]
K562	IC₅₀	41.6 μM Compound: 6l, NR-160	Cytotoxicity in human K562 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human K562 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]
MOLT-4	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human MOLT-4 cells Antiproliferative activity against human MOLT-4 cells	[PMID: 37875056]
MOLT-4	IC₅₀	42.4 μM Compound: 6l, NR-160	Cytotoxicity in human MOLT-4 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human MOLT-4 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]
SUP-B15	IC₅₀	22.5 μM Compound: 6l, NR-160	Cytotoxicity in human SUP-B15 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human SUP-B15 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]
SUP-B15	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human SUP-B15 cells Antiproliferative activity against human SUP-B15 cells	[PMID: 37875056]
TALL-1	IC₅₀	22.5 μM Compound: 76; NR-160	Antiproliferative activity against human TALL-1 cells Antiproliferative activity against human TALL-1 cells	[PMID: 37875056]
TALL-1	IC₅₀	49.4 μM Compound: 6l, NR-160	Cytotoxicity in human TALL-1 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay Cytotoxicity in human TALL-1 cells assessed as reduction in cell viability incubated for 72 hrs by cell-Titer-Glo luminescent cell viability assay	[PMID: 32803970]

In Vitro

NR160 (compound 6I) (2.5 μM and 5 μM; 24 h) induces α-tubulin acetylation (ac-α-tubulin)^[1].
NR160 (1-50 μM; 24 h) shows low cytotoxicity against leukemia cell lines with IC50s >20 μM^[1].
NR160 (2.5 μM, 5 μM; 24 h) enhances the cytotoxicity induction of Bortezomib, Epirubicin and Daunorubicin in HL60 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

HL60 cells
Concentration:

1-50 μM
Incubation Time:

24 hours
Result:

Inhibited leukemia cell lines with IC50s of 49.4 μM (TALL-1), 51.8 μM (HSB-2), 42.4 μM (MOLT-4), 32.1 μM (Jurkat), 42.9 μM (HL-60), 22.5 μM (SUP-B15), and 41.6 μM (K562), respectively.

Chemical Information

CAS. Nr. 2484895-50-1
Appearance Solid
Molecular Weight 510.47
Formel C₂₅H₂₁F₃N₆O₃
Color White to off-white
SMILES

O=C(N(CC1=CC=C(C(NO)=O)C=C1)CC2=NN=NN2CC3=CC=CC=C3)C4=CC=CC=C4C(F)(F)F
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (277 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Reßing N, et al. Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups. J Med Chem. 2020 Sep 24;63(18):10339-10351. [Content Brief]

[2]. Najib N N, et al. Correlation between the acoustic and dynamic mechanical properties of natural rubber foam: Effect of foaming temperature[J]. Materials & Design, 2011, 32(2): 505-511.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen